AU
OCUL icon

AlphaGrep UK’s Ocular Therapeutix OCUL Stock Holding History

AlphaGrep UK’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Sell
15,985
-16,941
-51% -$154K 0.05% 698
2026
Q1 		$279K Buy
+32,926
New +$314K 0.08% 548

Other funds holding OCUL

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

AlphaGrep UK's OCUL Position: Q2 2026 in Review

AlphaGrep UK reduced its Ocular Therapeutix (OCUL) stake by 51% in Q2 2026, selling an estimated $154K and leaving 15,985 shares worth $157K. The position accounts for 0.05% of the portfolio, ranked #698.

AlphaGrep UK first reported a position in OCUL in Q1 2026 and has held it in 2 quarters since. The position peaked at $279K in Q1 2026. 237 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • AlphaGrep UK held 15,985 shares of Ocular Therapeutix worth $157K as of Q2 2026.
  • AlphaGrep UK sold 16,941 Ocular Therapeutix shares in Q2 2026, an estimated $154K.
  • Ocular Therapeutix made up 0.05% of AlphaGrep UK's portfolio in Q2 2026, its #698 holding.
  • AlphaGrep UK first reported a position in Ocular Therapeutix in Q1 2026 and has held it in 2 quarters since.
  • AlphaGrep UK's Ocular Therapeutix position peaked at $279K in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.